Is Hemant Surgical Industries a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Hemant Surgical Industries Ltd is a average quality company .

Is Hemant Surgical Industries undervalued or overvalued?

The key valuation ratios of Hemant Surgical Industries Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is Hemant Surgical Industries share price return in the past 10 years?

Data is not available for this company

Is Hemant Surgical Industries a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Hemant Surgical Industries Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the P/E ratio of Hemant Surgical Industries?

The latest standalone P/E ratio of Hemant Surgical Industries as of 21-Nov-2024 is 13.85.

What is the P/B ratio of Hemant Surgical Industries?

The latest standalone P/B ratio of Hemant Surgical Industries as of 21-Nov-2024 is 2.47.

What is the 52-week high and low of Hemant Surgical Industries?

The 52-week high of Hemant Surgical Industries is Rs. 224.90 and the 52-week low is Rs. 115.00.

Hemant Surgical Industries Ltd - Stock Valuation and Financial Performance

Name: Hemant Surgical Industries
Brand: Hemant Surgical Industries

BSE: 543916 | NSE: | Medical Equipment/Supplies/Accessories | Small Cap

Place order

Hemant Surgical Inds Share Price

₹130 6.15 4.97%
as on 21-Nov'24 16:59

10 Year X-Ray of Hemant Surgical Inds:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	13.2%	15.7%	14.8%	14.5%	15.2%	11.6%	14.3%	32.9%	45.2%	29.9%	-
Value Creation Index ⓘ	-0.1	0.1	0.1	0.0	0.1	-0.2	0.0	1.4	2.2	1.1	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	31.8	39.6	51.5	50.6	55.7	56.1	59.8	104	109	106	106
Sales YoY Gr.	-	24.7%	30%	-1.8%	10.1%	0.8%	6.5%	73.3%	5.4%	-3.2%	-
Adj EPS ⓘ	2.2	2.6	2.8	2.9	3.5	2.7	3.6	10.6	8.6	8.5	9.4
YoY Gr.	-	17%	6.1%	5.8%	20.8%	-24.3%	33.6%	195.5%	-18.5%	-1.7%	-
BVPS (₹) ⓘ	18.7	20.4	20.2	21	23.7	25.1	26.7	41.1	30.4	52.6	52.6
Adj Net Profit ⓘ	0.5	0.6	0.8	0.9	1.1	0.9	1.1	3.4	6.6	8.8	10
Cash Flow from Ops. ⓘ	0	0	0	0	0	0	-0.3	12.1	6.3	-7.6	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	-53.4	0.8	1.1	-0.9	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	14.3%	13.7%	20.9%	-3.2%
Adj EPS ⓘ	16%	19.1%	33.3%	-1.7%
BVPSⓘ	12.2%	17.2%	25.4%	72.8%
Share Price	-	-	-	-25.7%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	12.5	13.3	14.9	15	15.8	11	12.9	29.5	36.3	22.6	17.9
Op. Profit Mgn % ⓘ	4.5	5.9	4.7	4.9	4.8	4.6	5.9	6.1	9.7	9.9	NAN
Net Profit Mgn % ⓘ	1.7	1.6	1.6	1.9	2	1.5	1.9	3.3	6.1	8.4	9.3
Debt to Equity ⓘ	2.2	2.3	1.9	1.3	1.5	1.8	1.7	0.7	0.3	0.1	-
Working Cap Days ⓘ	276	216	150	140	142	168	171	114	132	179	0
Cash Conv. Cycle ⓘ	85	53	32	14	5	18	30	20	17	36	0

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 20.90%

Net Profit is growing at healthy rate in last 3 years 33.25%

Return on Equity has declined versus last 3 years average to 17.90%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Hemant Surgical Industries Ltd.

	Standalone	Consolidated
TTM EPS (₹)	9.4	-
TTM Sales (₹ Cr.)	106	-
BVPS (₹.) ⓘ	52.6	-
Reserves (₹ Cr.) ⓘ	44	-
P/BV ⓘ	2.47	-
PE ⓘ	13.85	-

From the Market
52 Week Low / High (₹)	115.00 / 224.90
All Time Low / High (₹)	115.00 / 260.00
Market Cap (₹ Cr.)	136
Equity (₹ Cr.)	10.4
Face Value (₹)	10
Industry PE ⓘ	78.6

Management X-Ray of Hemant Surgical Inds:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Hemant Surgical Inds

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Hemant Surgical Inds

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	32	40	51	51	56	56	60	104	109	106
Operating Expenses ⓘ	30	37	49	48	53	54	57	97	99	95
Manufacturing Costs	0	1	1	1	1	2	1	1	2	2
Material Costs	28	33	44	42	45	44	47	82	80	78
Employee Cost	1	1	1	2	2	2	3	5	6	6
Other Costs ⓘ	2	2	2	4	5	5	6	10	11	10
Operating Profit ⓘ	1	2	2	2	3	3	3	6	11	10
Operating Profit Margin (%)	4.4%	5.9%	4.7%	4.9%	4.8%	4.6%	5.1%	6.1%	9.7%	9.9%
Other Income ⓘ	1	0	0	0	0	0	1	2	2	4
Interest ⓘ	1	2	2	1	1	1	2	2	2	1
Depreciation ⓘ	0	0	0	0	1	1	1	1	1	1
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	1	1	1	1	1	1	2	6	10	13
Tax ⓘ	0	0	0	0	0	0	0	1	2	3
Profit After Tax	1	1	1	1	1	1	1	5	8	10
PAT Margin (%)	1.7%	1.6%	1.6%	1.9%	2.0%	1.5%	1.9%	4.5%	7.0%	9.3%
Adjusted EPS (₹)	2.2	2.6	2.8	2.9	3.5	2.7	3.6	14.4	9.9	9.4
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	4	5	6	7	8	8	9	13	23	55
Share Capital ⓘ	2	2	2	2	2	2	2	2	8	10
Reserves ⓘ	3	3	4	5	6	6	7	11	16	44
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	10	11	11	9	11	14	13	9	5	6
Long Term Debt	1	3	3	5	6	9	10	4	3	4
Short Term Debt	9	8	8	4	5	5	3	4	2	2
Trade Payables	11	10	9	12	12	15	13	21	24	25
Others Liabilities ⓘ	1	2	1	1	2	4	8	12	12	11
Total Liabilities ⓘ	26	28	27	28	33	41	43	54	65	97
Fixed Assets
Gross Block	4	7	6	7	8	10	16	16	19	24
Accumulated Depreciation	3	3	0	0	1	1	4	5	6	6
Net Fixed Assetsⓘ	1	4	6	7	8	9	12	12	13	18
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investmentsⓘ	0	0	0	0	0	0	1	1	0	5
Inventories	14	11	7	7	9	15	15	13	15	21
Trade Receivables	5	6	7	5	5	5	4	16	17	22
Cash Equivalents	1	1	1	2	1	4	2	6	8	13
Others Assetsⓘ	5	6	5	7	9	8	9	8	11	18
Total Assets ⓘ	26	28	27	28	33	41	43	54	65	97

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	0	12	6	-8
PBT ⓘ	2	6	10	13
Adjustment ⓘ	2	2	4	1
Changes in Working Capital ⓘ	-4	4	-5	-18
Tax Paid ⓘ	0	0	-3	-3
Cash Flow From Investing Activity ⓘ	-2	0	-3	-9
Capex	-2	0	-4	-6
Net Investments	0	0	0	-5
Others ⓘ	0	0	1	1
Cash Flow From Financing Activityⓘ	1	-8	-1	21
Net Proceeds from Shares ⓘ	1	-1	3	22
Net Proceeds from Borrowing ⓘ	3	-6	-2	0
Interest Paid ⓘ	-2	-2	-2	-1
Dividend Paid ⓘ	0	0	0	0
Others ⓘ	-2	1	0	0
Net Cash Flow ⓘ	-2	4	3	5

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	12.5	13.31	14.89	14.98	15.82	11	13.84	42.56	41.84	25.06
ROCE (%)	13.17	15.66	14.76	14.51	15.23	11.64	14.34	32.89	45.15	29.87
Asset Turnover Ratio	1.21	1.48	1.9	1.85	1.82	1.51	1.42	2.13	1.83	1.31
PAT to CFO Conversion(x)	0	0	0	0	0	0	0	2.4	0.75	-0.8
Working Capital Days
Receivable Days	59	48	47	44	34	35	30	35	55	67
Inventory Days	171	118	65	52	53	78	91	49	46	62
Payable Days	149	114	76	90	95	114	108	75	102	115

Hemant Surgical Industries Ltd Stock News

Hemant Surgical Industries Ltd FAQs

What is the share price of Hemant Surgical Inds?

Company share prices are keep on changing according to the market conditions. The closing price of Hemant Surgical Inds on 21-Nov-2024 16:59 is ₹130.0.

What is the market cap of Hemant Surgical Inds?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:59 the market cap of Hemant Surgical Inds stood at ₹135.7.

What is the P/E ratio of Hemant Surgical Inds?

The latest P/E ratio of Hemant Surgical Inds as of 21-Nov-2024 16:59 is 13.85.

What is the P/B ratio of Hemant Surgical Inds?

The latest P/B ratio of Hemant Surgical Inds as of 21-Nov-2024 16:59 is 2.47.

What is the 52-week high and low of Hemant Surgical Inds?

The 52-week high of Hemant Surgical Inds is ₹224.9 and the 52-week low is ₹115.0.

What is the TTM revenue of Hemant Surgical Inds?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Hemant Surgical Inds is ₹105.6 ( Cr.) .

About Hemant Surgical Industries Ltd

The company was originally incorporated as ‘Hemant Surgical Industries Private Limited’ under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated March 27, 1989, by Registrar of Companies, Maharashtra, Mumbai. Subsequently the company was converted into a public limited company vide special resolution passed by the shareholders at the Extra Ordinary General Meeting held on January 24, 1994 and the name of the company was changed from ‘Hemant Surgical Industries Private Limited’ to ‘Hemant Surgical Industries Limited’ vide fresh Certificate of Incorporation granted to the company consequent upon conversion into public limited company dated February 22, 1994 by the Registrar of Companies, Maharashtra, Mumbai.

The company manufactures, import, assemble and market a comprehensive portfolio of medical equipments and disposables. Its product offerings cover a wide spectrum of equipments and disposables required for (i) Renal Care, (ii) cardiovascular disease (iii) respiratory disease, (iv) Critical Care and Radiology and (v) Surgical disposables. Its wide range of products includes some of the indigenously manufactured products along with some other products that are imported from countries like: Japan, China France and Australia and are further processed in its assembly units. In addition it is also providing services for maintenance and running of dialysis centres.

The company started its operations with importing and marketing of medical disposables like: meditapes, all over India from JMS Company Japan. Later in the year 1999 the company started its manufacturing operations with one Manufacturing unit and over the years expanded its manufacturing and assembly operations to two more additional units. Its facilities are ISO 9001:2015 and ISO 13485:2016 certified having fully equipped quality control department with experienced and qualified staff to facilitate smooth manufacturing and assembly line process. The company was founded in the year 1989 by one of its Promoters, Hanskumar Shamji Shah, who has over 35 years of experience in the industry.

Business of the company

Hemant surgical Industries is engaged in the business of manufacturing, importing, assembly and marketing of medical equipments and disposables.

Products of the company

Healthcare products and medical equipments

Hemodialysis machine
Dialysis Solution - Acidic and bicarbonate
Dialyzer
ECG machine
ECG electrode
Nebulizer
Paramonitors
Ultrasound machine
Ventilator

Surgical disposables

Meditape
Intravenous infusion set
Scalp vein set
Foley catheter
3 Ply masks

Other healthcare products

Digital thermometer
Cold and hot sterilant
Fully automatic comfort dialysis chair
Five-Function electric ICU bed with mattress

History and milestones

1989: Incorporation of the company in the name of ‘Hemant Surgical Private Limted’.
1993: Became the Sole Agent for JMS Co. Ltd, Japan, for JMS, Meditape.
1994: Conversion into Public Limited company with the name Hemant Surgical Industries Ltd.
1999: Started its first manufacturing plant at Achhad, Maharashtra for External Preparation and Small Volume Parentals.
2018: Entered into exclusive distribution agreement dated July 01, 2018, valid for a period of 6 years, with JMS Co. Ltd., Japan for importing and marketing JMS Meditape in India. The imported meditape undergoes the process of rewinding, slitting, and packaging in its assembly unit situated at Atgaon and is then sold in Indian market.
2019: Entered into technical collaboration agreement with JMS Singapore Pte. Ltd. for manufacturing Intravenous Infusion Set which are sold under the brand name ‘JMS’ in India.
2019: Signed exclusive distribution agreement with Hemant Phillipines Inc./ Mediply Inc. for supply of renal care equipment, medical devices and consumables for marketing the same in entire Phillipines.
2021: Appointed as sole agent of SWS Hemodialysis Care Co. Ltd., Chinato sell and do maintenance of SWS4000A hemodialysis machines in West India on exclusive basis.
2021: Entered into MOU with Dr. Venkatesh for setting up of dialysis centre at Guru Harikrishan Hospital 24x7 Dialysis Centre, New Delhi.
2022: Achieved a Bench mark of 100 Cr Turnover in the FY 2021-22.